Sharon Dekel, PhD, an Assistant Professor of Harvard Medical School and a researcher and psychologist in the Department of Psychiatry at Massachusetts General Hospital, is studying childbirth-related posttraumatic stress disorder (CB-PTSD), a condition that may affect as many as 5-11% of postpartum women.
Blog
A team of researchers from Massachusetts General Hospital are exploring the role of lifestyle factors such as stress in the onset and progression of Alzheimer’s disease.
A recent article in the Harvard Crimson took an in-depth look at how treating the victims of the Cocoanut Grove Fire in Boston contributed to a Massachusetts General Hospital psychiatrist’s research and clinical work into how people experience and process losses due to death or injury.
Researchers from the Martinos Center for Biomedical Imaging at Massachusetts General Hospital has developed a new testing protocol to screen infants, toddlers and young children for autism spectrum disorder (ASD) using eye tracking software. The tool could increase early detection rates and reduce the time and cost of current screening techniques.
In a recent article in Annals of Surgery, a research team from Massachusetts General Hospital and MIT details the ways in which artificial intelligence (AI) could revolutionize the practice and teaching of surgery—and how patients will benefit with safer surgeries and better outcomes.
In a city where most residents are within a short distance of world class academic medical centers, and in a state that makes health insurance available to all, why is there such a such a disparity in life expectancy among the residents of three Boston neighborhoods?
I’m an 11th-grader at the International School of Boston and for the past 5 days, I have been working as a communications intern in the Office of the Scientific Director at the Mass General Research Institute. Here’s an overview of what I worked on and what I learned! Day 1 To be honest, I feltRead more
Can a light-based treatment called photobiomodulation help to treat degenerative brain diseases?
The REVIVE clinical trial team is seeking feedback from the public on their study testing the use of RESQFOAM in severely injured trauma patients.
Harald Jueppner, MD Advances in medical care often take a long and winding path from a new laboratory discovery to the patient bedside. So it is particularly gratifying as a physician-scientist when you have the opportunity to offer your patients a new treatment that came about in part from research in your own laboratory. ForRead more